{"id":"fluzone-by-sanofi-pasteur","safety":{"commonSideEffects":[{"effect":"Pain at the injection site","drugRate":"50.7%","placeboRate":"","totalAtRisk":2115,"totalAffected":1072,"trialsReporting":1},{"effect":"Redness at the injection site","drugRate":"19.9%","placeboRate":"","totalAtRisk":2115,"totalAffected":421,"trialsReporting":1},{"effect":"Muscle aches","drugRate":"19.4%","placeboRate":"","totalAtRisk":2115,"totalAffected":410,"trialsReporting":1},{"effect":"Swelling at the injection site","drugRate":"14.6%","placeboRate":"","totalAtRisk":2115,"totalAffected":308,"trialsReporting":1},{"effect":"Fatigue","drugRate":"13.5%","placeboRate":"","totalAtRisk":2115,"totalAffected":285,"trialsReporting":1},{"effect":"Irritability","drugRate":"11.0%","placeboRate":"","totalAtRisk":2115,"totalAffected":232,"trialsReporting":1},{"effect":"Headache","drugRate":"10.3%","placeboRate":"","totalAtRisk":2115,"totalAffected":218,"trialsReporting":1},{"effect":"Drowsiness","drugRate":"7.6%","placeboRate":"","totalAtRisk":2115,"totalAffected":160,"trialsReporting":1},{"effect":"Axillary fever","drugRate":"7.2%","placeboRate":"","totalAtRisk":2115,"totalAffected":152,"trialsReporting":1},{"effect":"Loss of appetite","drugRate":"6.2%","placeboRate":"","totalAtRisk":2115,"totalAffected":131,"trialsReporting":1},{"effect":"Upper respiratory tract infection","drugRate":"5.5%","placeboRate":"","totalAtRisk":2115,"totalAffected":116,"trialsReporting":1},{"effect":"Pyrexia","drugRate":"4.8%","placeboRate":"","totalAtRisk":2115,"totalAffected":102,"trialsReporting":1},{"effect":"Cough","drugRate":"4.7%","placeboRate":"","totalAtRisk":2115,"totalAffected":100,"trialsReporting":1},{"effect":"Arthralgia","drugRate":"4.0%","placeboRate":"","totalAtRisk":2115,"totalAffected":85,"trialsReporting":1}]},"_chembl":null,"_dailymed":null,"_scrapedAt":"2026-03-28T06:04:48.192Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T10:20:03.856166+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT06824779","phase":"PHASE4","title":"Impact of FLU Vaccination on Nasal Resident Memory Immune Responses and Peripheral Respiratory-tropic Memory Immune Responses","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2025-12-05","conditions":"Volunteers, Flu Vaccine","enrollment":30},{"nctId":"NCT05801978","phase":"PHASE4","title":"Durability of Vaccine Responses","status":"RECRUITING","sponsor":"Emory University","startDate":"2023-04-11","conditions":"Vaccine Response","enrollment":66},{"nctId":"NCT06054269","phase":"PHASE3","title":"Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centers for Disease Control and Prevention","startDate":"2022-11-04","conditions":"Influenza","enrollment":192},{"nctId":"NCT05895955","phase":"PHASE1, PHASE2","title":"Safety and Immunogenicity of GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine in Healthy Thais","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mahidol University","startDate":"2023-11-04","conditions":"Influenza","enrollment":290},{"nctId":"NCT03722589","phase":"PHASE4","title":"Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2018-09-12","conditions":"Influenza","enrollment":944},{"nctId":"NCT06286488","phase":"PHASE4","title":"Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2020-09-15","conditions":"Influenza, Obesity, Pregnancy; Infection","enrollment":1500},{"nctId":"NCT03777163","phase":"PHASE4","title":"Safety and Immunogenicity of the Butantan Institute Influenza Vaccine Compared to Sanofi Pasteur Influenza Vaccine","status":"COMPLETED","sponsor":"Butantan Institute","startDate":"2019-04-22","conditions":"Influenza","enrollment":632},{"nctId":"NCT02957890","phase":"PHASE4","title":"Immunogenicity of Twice-annual Influenza Vaccination in Older Adults in Hong Kong","status":"ACTIVE_NOT_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2016-11-18","conditions":"Influenza, Human","enrollment":400},{"nctId":"NCT03330132","phase":"PHASE4","title":"Immunogenicity of Alternative Annual Influenza Vaccination Strategies in Older Adults in Hong Kong","status":"ACTIVE_NOT_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2017-10-07","conditions":"Influenza, Human","enrollment":1861},{"nctId":"NCT04523324","phase":"PHASE4","title":"Immunogenicity Trial of Recombinant Influenza Vaccine Among HCP in Israel","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2019-10-31","conditions":"Influenza","enrollment":577},{"nctId":"NCT05129436","phase":"","title":"Adaptive Immune Response to Seasonal Influenza Vaccination (AIGI)","status":"UNKNOWN","sponsor":"University Medicine Greifswald","startDate":"2020-10-10","conditions":"Seasonal Influenza Vaccination","enrollment":20},{"nctId":"NCT05297994","phase":"PHASE2","title":"Trial of the Reactogenicity, Safety and Immunogenicity of the Flu-M Vaccine Manufactured by FSUE SPbSRIVS FMBA","status":"COMPLETED","sponsor":"St. Petersburg Research Institute of Vaccines and Sera","startDate":"2016-10-24","conditions":"Influenza","enrollment":400},{"nctId":"NCT04515368","phase":"NA","title":"A Pilot Clinical Study of PET Scanning in Evaluation of Vaccine Reactogenicity","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2016-06-10","conditions":"Positron-Emission Tomography, Immunization Reaction","enrollment":54},{"nctId":"NCT01653015","phase":"PHASE4","title":"Live Versus Inactivated Influenza Vaccine Study in Hutterite Children","status":"COMPLETED","sponsor":"McMaster University","startDate":"2012-11","conditions":"Influenza","enrollment":4611},{"nctId":"NCT00383071","phase":"PHASE2","title":"Development of Immune Globulin Treatment for Avian Flu","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-08","conditions":"Infectious Diseases, Influenza, Avian Flu","enrollment":126},{"nctId":"NCT00383123","phase":"PHASE3","title":"Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-11-02","conditions":"Influenza","enrollment":3327},{"nctId":"NCT00538512","phase":"PHASE4","title":"Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2007-09","conditions":"Influenza","enrollment":1952},{"nctId":"NCT01368796","phase":"PHASE4","title":"Comparison of 4 Influenza Vaccines in Seniors","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2011-07","conditions":"Influenza Vaccine","enrollment":953},{"nctId":"NCT01189123","phase":"NA","title":"Cell Mediated Immunity in Older Adults","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2010-08","conditions":"Immunity to Influenza Vaccine","enrollment":105},{"nctId":"NCT01810731","phase":"PHASE2, PHASE3","title":"Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya","status":"WITHDRAWN","sponsor":"Centers for Disease Control and Prevention","startDate":"2014-04","conditions":"Influenza, Human, HIV, Malaria","enrollment":""},{"nctId":"NCT01317745","phase":"PHASE1","title":"H5N1 Mix and Match With MF59","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2011-05","conditions":"Influenza","enrollment":270},{"nctId":"NCT01317758","phase":"PHASE1","title":"H5N1 Mix and Match With AS03","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2011-05","conditions":"Influenza","enrollment":245},{"nctId":"NCT00504231","phase":"PHASE2","title":"Intradermal Influenza Vaccine Study in Elders","status":"COMPLETED","sponsor":"PATH","startDate":"2007-09","conditions":"Influenza","enrollment":257},{"nctId":"NCT00877396","phase":"PHASE4","title":"Hutterite Influenza Prevention Study","status":"COMPLETED","sponsor":"McMaster University","startDate":"2008-09","conditions":"Influenza","enrollment":4771},{"nctId":"NCT00710866","phase":"PHASE3","title":"Influenza Vaccine Dose-Response in Infants and Toddlers: Immunogenicity and Reactogenicity","status":"COMPLETED","sponsor":"British Columbia Centre for Disease Control","startDate":"2008-08","conditions":"Influenza","enrollment":262},{"nctId":"NCT00311675","phase":"PHASE1, PHASE2","title":"St. Jude Open Label H5 Trial","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-04","conditions":"Influenza","enrollment":35}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":23,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"fluzone by sanofi pasteur","genericName":"fluzone by sanofi pasteur","companyName":"Vanderbilt University","companyId":"vanderbilt-university","modality":"Biologic","firstApprovalDate":"","aiSummary":"","enrichmentLevel":5,"visitCount":1,"trialStats":{"total":6,"withResults":3},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T10:20:03.856166+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":true,"trials":true,"score":2}}